<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">Of course COVID-19 is the most recent epidemic rapidly spreading around the world with disastrous consequences for many people. In China there is rapidly growing body of experience and research about the use of traditional medicine alongside conventional treatment to treat COVID-19. This special issue contains a paper by Ho et al. (
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.eujim.2020.101116" id="intr0015" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.1016/j.eujim.2020.101116</ext-link>) describing the official China National Guidelines for treating COVID-19 with Traditional Chinese Medicine. Zhang et al. (
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.eujim.2019.101045" id="intr0020" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.1016/j.eujim.2019.101045</ext-link>) describe in their paper the quality assessment of clinical practice guidelines for the use of Chinese and Western medicine for acute bronchitis. This paper shows that the quality of guidelines concerning Chinese medicines is still insufficient and provides recommendations for improvement. These papers are examples of what is needed to employ traditional medicine in a standardized manner to treat known or unknown infectious diseases and thereby contribute to a reduction of AMR.
</p>
